Related Experiment Video

Updated: Oct 5, 2025

A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
05:31

A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels

Published on: April 24, 2012

14.5K

LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells

Concetta Caglioti1,2, Federico Palazzetti1, Lorenzo Monarca1,2

  • 1Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy.

Frontiers in Physiology
|January 24, 2022
PubMed

Insights

This study reveals how phosphatidylinositol 3-kinase class II beta (PI3KC2β) regulates KCa3.1 channels in glioblastoma cells. This finding suggests new therapeutic strategies targeting glioblastoma resistance.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cell Physiology

Background:

  • Glioblastomas (GBs) are aggressive central nervous system tumors.
  • Malignancy involves altered protein kinase and ion channel activity.
  • Phosphatidylinositol 3-kinase (PI3K) and KCa3.1 channels are implicated in GB biology.

Purpose of the Study:

  • To investigate the role of PI3K in regulating KCa3.1 channel activity in glioblastomas.
  • To elucidate the specific PI3K class involved and its mechanism of action.
  • To explore therapeutic implications for glioblastoma treatment.

Main Methods:

  • Electrophysiological approaches and noise analysis were employed.
  • Investigated KCa3.1 channel activity modulation by PI3K inhibitors (LY294002, Wortmannin).
  • Examined channel behavior during endogenous KCa3.1 activation (histamine).

Main Results:

  • KCa3.1 channel activity was sensitive to LY294002 but resistant to Wortmannin, indicating PI3K class II beta (PI3KC2β) involvement.
  • PI3KC2β reduced the open probability of KCa3.1 channels at saturating intracellular calcium concentrations.
  • A regulatory mechanism based on the "three-gate" model of the KCa3.1 channel was proposed.

Conclusions:

  • PI3KC2β plays a key role in modulating KCa3.1 channel function in glioblastoma.
  • Understanding this interaction offers potential therapeutic targets to overcome chemo- and radioresistance in glioblastomas.
  • This research highlights a novel pathway for glioblastoma treatment strategies.
Keywords:
KCa3.1 (intermediate-conductance Ca2+-activated K+ channel)LY294002 (PI3K inhibitor)calcium homeostasischemio and radioresistanceglioblastomahistamine (H1) receptor

More Related Videos

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting10:08

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

2.3K
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy09:17

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Published on: September 16, 2019

6.9K

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.9K